AXGN - AxoGen, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Alachua,
United States
Type: Equity
AXGN price evolution
AXGN
| (in millions $) | 30 Oct 2024 | 30 Jul 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $25.19 | $21.71 | $37.03 | |
| Short term investments | $1.94 | $1.92 | ||
| Net receivables | $24.63 | $25.15 | $24.21 | $25.15 |
| Inventory | $29.36 | $28.02 | $27.64 | $23.02 |
| Total current assets | $86.25 | $82.26 | $78.66 | $88 |
| Long term investments | ||||
| Property, plant & equipment | $100.52 | $101.7 | $103.08 | $104.29 |
| Goodwill & intangible assets | $4.97 | $4.77 | $4.53 | |
| Total noncurrent assets | $106.67 | $107.85 | $108.82 | |
| Total investments | $1.94 | $1.92 | ||
| Total assets | $191.99 | $188.93 | $186.52 | $196.83 |
| Current liabilities | ||||
| Accounts payable | $21.18 | $21.66 | $21.29 | $28.88 |
| Deferred revenue | ||||
| Short long term debt | $1.75 | $1.64 | $1.55 | |
| Total current liabilities | $23.03 | $23.41 | $22.93 | $30.43 |
| Long term debt | $47.29 | $47.06 | $70.43 | $70.73 |
| Total noncurrent liabilities | $69.83 | $70.43 | $70.73 | |
| Total debt | $71.49 | $72.07 | $72.28 | |
| Total liabilities | $92.58 | $93.25 | $93.36 | $101.16 |
| Shareholders' equity | ||||
| Retained earnings | -$291.71 | -$289.85 | -$287.93 | -$281.3 |
| Other shareholder equity | ||||
| Total shareholder equity | $95.69 | $93.16 | $95.67 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $37.03 | $21.54 | $39.01 | $55.61 |
| Short term investments | $33.51 | $51.33 | $55.2 | |
| Net receivables | $25.15 | $22.19 | $18.16 | $17.62 |
| Inventory | $23.02 | $18.91 | $16.69 | $12.53 |
| Total current assets | $88 | $98.08 | $127.05 | $145.25 |
| Long term investments | ||||
| Property, plant & equipment | $104.29 | $93.66 | $78.12 | $54.08 |
| Goodwill & intangible assets | $4.53 | $3.65 | $2.86 | $2.05 |
| Total noncurrent assets | $108.82 | $97.31 | $80.97 | $56.13 |
| Total investments | $33.51 | $51.33 | $55.2 | |
| Total assets | $196.83 | $195.39 | $208.02 | $201.38 |
| Current liabilities | ||||
| Accounts payable | $28.88 | $8.96 | $22.46 | $21.97 |
| Deferred revenue | ||||
| Short long term debt | $1.55 | $1.31 | $1.83 | $0.86 |
| Total current liabilities | $30.43 | $23.75 | $24.29 | $22.83 |
| Long term debt | $70.73 | $45.73 | $71.18 | $55.4 |
| Total noncurrent liabilities | $70.73 | $70.64 | $71.18 | $55.4 |
| Total debt | $72.28 | $71.94 | $73.02 | $56.26 |
| Total liabilities | $101.16 | $94.39 | $95.47 | $78.23 |
| Shareholders' equity | ||||
| Retained earnings | -$281.3 | -$259.58 | -$230.63 | -$203.65 |
| Other shareholder equity | ||||
| Total shareholder equity | $95.67 | $101 | $112.55 | $123.15 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $47.91 | $41.38 | $42.92 | |
| Cost of revenue | $12.57 | $8.76 | $9.16 | |
| Gross Profit | $35.34 | $32.62 | $33.76 | |
| Operating activities | ||||
| Research & development | $6.66 | $7.41 | $7.3 | |
| Selling, general & administrative | $29.11 | $29.77 | $29.66 | |
| Total operating expenses | $35.77 | $37.18 | $36.96 | |
| Operating income | -$0.43 | -$4.56 | -$3.19 | |
| Income from continuing operations | ||||
| EBIT | $0.26 | -$4.31 | -$2.05 | |
| Income tax expense | ||||
| Interest expense | $2.19 | $2.33 | $1.84 | |
| Net income | ||||
| Net income | -$1.92 | -$6.63 | -$3.89 | |
| Income (for common shares) | -$1.92 | -$6.63 | -$3.89 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $159.01 | $138.58 | $127.36 | $112.3 |
| Cost of revenue | $31.14 | $24.15 | $22.93 | $21.58 |
| Gross Profit | $127.87 | $114.44 | $104.43 | $90.72 |
| Operating activities | ||||
| Research & development | $28.33 | $27.16 | $24.18 | $17.85 |
| Selling, general & administrative | $121 | $116.99 | $105.67 | $96.06 |
| Total operating expenses | $149.34 | $144.14 | $129.84 | $113.9 |
| Operating income | -$21.46 | -$29.71 | -$25.42 | -$23.18 |
| Income from continuing operations | ||||
| EBIT | -$18.88 | -$28.32 | -$25.63 | -$22.73 |
| Income tax expense | ||||
| Interest expense | $2.83 | $0.62 | $1.36 | $1.05 |
| Net income | ||||
| Net income | -$21.72 | -$28.95 | -$26.98 | -$23.79 |
| Income (for common shares) | -$21.72 | -$28.95 | -$26.98 | -$23.79 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$1.92 | -$6.63 | -$3.89 | |
| Operating activities | ||||
| Depreciation | $2.06 | $1.9 | $1.85 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $3.91 | $3.92 | $1.33 | |
| Total cash flows from operations | $4.17 | -$12.27 | -$0.21 | |
| Investing activities | ||||
| Capital expenditures | -$0.91 | -$0.92 | -$1.46 | |
| Investments | -$0 | -$1.91 | $1.5 | |
| Total cash flows from investing | -$9.48 | -$1.23 | -$3.25 | -$0.28 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.55 | $0.21 | $0.42 | |
| Net borrowings | -$0 | -$0 | -$0 | |
| Total cash flows from financing | $1.32 | $0.54 | $0.2 | $0.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$12.36 | $3.48 | -$15.31 | -$0.07 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$21.72 | -$28.95 | -$26.98 | -$23.79 |
| Operating activities | ||||
| Depreciation | $5.55 | $4.85 | $4.74 | $3.46 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $14.42 | $15.59 | $10.92 | $8.47 |
| Total cash flows from operations | -$5.72 | -$16.07 | -$13.4 | -$9.63 |
| Investing activities | ||||
| Capital expenditures | -$13.87 | -$20.08 | -$27.81 | -$21.91 |
| Investments | $34.17 | $18.05 | $3.8 | $5.63 |
| Total cash flows from investing | $19.25 | -$3.2 | -$23.65 | -$16.96 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.96 | $1.81 | $6.8 | |
| Net borrowings | -$0.01 | -$0.01 | $14.98 | $34.99 |
| Total cash flows from financing | $1.95 | $1.79 | $20.45 | $40.47 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $15.49 | -$17.47 | -$16.6 | $13.88 |
News
Fundamentals
| Market cap | $792.04M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 44.00M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.06 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.74 |
| Quick ratio | 2.47 |